Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ovarian cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06145295
What this trial is testing

The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life

Who this might be right for
Ovarian Cancer
Shanghai Jiao Tong University School of Medicine 68
Not applicableStudy completedNCT03673995
What this trial is testing

Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS

Who this might be right for
Polycystic Ovary SyndromeMenstrual ProblemHirsutism
Pharmarte srl 186
Not applicableStudy completedNCT04214210
What this trial is testing

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

Who this might be right for
Hereditary CancerBreast CancerOvarian Cancer
University of Basel 128
Testing effectiveness (Phase 2)Study completedNCT02289950
What this trial is testing

Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian Cancer

Who this might be right for
Platinum-Sensitive Ovarian Cancer in First Relapse
Eisai Inc. 332
Not applicableUnknownNCT06182917
What this trial is testing

Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
West China Second University Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00017017
What this trial is testing

CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT03690440
What this trial is testing

Study Describing the Coverage, Cares and the Fertility of Patients of Less Than 45 Years With a Borderline Ovarian Tumor

Who this might be right for
Borderline Ovarian Tumors
Institut Curie 176
Early research (Phase 1)Study completedNCT01264432
What this trial is testing

Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Adult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Active Not RecruitingNCT05075993
What this trial is testing

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Who this might be right for
Metastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more
M.D. Anderson Cancer Center 352
Not applicableStudy completedNCT02272439
What this trial is testing

Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan

Who this might be right for
Unexplained InfertilityPolycystic Ovarian SyndromeMale Infertility
University of Saskatchewan 118
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)UnknownNCT05211557
What this trial is testing

Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

Who this might be right for
Ovarian Cancer
The Affiliated Hospital of Xuzhou Medical University 15
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Not applicableLooking for participantsNCT06050109
What this trial is testing

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Who this might be right for
Breast Cancer FemaleEndocrine Therapy
Hongmei Zheng, PhD 1,200
Testing effectiveness (Phase 2)Study completedNCT02978495
What this trial is testing

Neoadjuvant Carboplatin in Triple Negative Breast Cancer

Who this might be right for
BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
Barretos Cancer Hospital 154
Large-scale testing (Phase 3)UnknownNCT00002477
What this trial is testing

Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Medical Research Council
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT02728492
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Who this might be right for
Non-small Cell Lung CancerEpithelial Ovarian Cancer
NewVac LLC 51
Large-scale testing (Phase 3)Study completedNCT00976911
What this trial is testing

AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 361
Testing effectiveness (Phase 2)UnknownNCT06509971
What this trial is testing

QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
West China Second University Hospital 39
Next Page